GDTC Stock Analysis: Buy, Sell, or Hold?
GDTC - CytoMed Therapeutics Limited Ordinary Shares
$0.92
0.00 (0.00%)
â˛
5d:
+5.63%
30d:
+0.99%
90d:
-4.27%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Jun 30, 2026
0d
Get Alerted When GDTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: GDTC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: GDTC is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: GDTC is currently trading at $0.92, which is considered fair relative to its 30-day fair value range of $0.85 to $0.95.
Technical Outlook: Technically, GDTC is in a downtrend. Immediate support is located at $0.71, while resistance sits at $0.98.
Market Sentiment: GDTC scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.16 (+352.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GDTC is in a downtrend. Immediate support is located at $0.71, while resistance sits at $0.98.
Market Sentiment: GDTC scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.16 (+352.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.85 -
$0.95
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 352.7% below Wall St target ($4.16)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.85 -
$0.95
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.71
Resistance Level
$0.98
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Wall Street Target
$4.16
(+352.7%)
Revenue Growth (YoY)
-15.9%
Share & Embed Analysis
Last updated: October 23, 2026 8:58 AM ET
Data refreshes hourly during market hours. Next update: 9:58 AM
Data refreshes hourly during market hours. Next update: 9:58 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GDTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 59 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 56 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 49 HOLD |
|
TRVI
Trevi Therapeutics Inc |
STRONG BUY
11 analysts |
$28 | 69 BUY |
